My Bibliography

select

Tarique M, Naz H, Suhail M, Turan A, Saini C, Muhammad N, Shankar H, Zughaibi TA, Khan TH, Khanna N, Sharma A. Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy. Front Immunol. 2023;14:1138145. doi: 10.3389/fimmu.2023.1138145. eCollection 2023. PubMed PMID: 37153623; PubMed Central PMCID: PMC10161389.

select

Muhammad N, Ruiz F, Stanley J, Rashmi R, Cho K, Jayachandran K, Zahner MC, Huang Y, Zhang J, Markovina S, Patti GJ, Schwarz JK. Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy. Cancer Res. 2022 Dec 16;82(24):4515-4527. doi: 10.1158/0008-5472.CAN-21-4369. PubMed PMID: 36214635; PubMed Central PMCID: PMC9772149.

select

Tarique M, Suhail M, Naz H, Muhammad N, Tabrez S, Zughaibi TA, Abuzenadah AM, Hashem AM, Shankar H, Saini C, Sharma A. Where do T cell subsets stand in SARS-CoV-2 infection: an update. Front Cell Infect Microbiol. 2022;12:964265. doi: 10.3389/fcimb.2022.964265. eCollection 2022. Review. PubMed PMID: 36034704; PubMed Central PMCID: PMC9399648.

select

Muhammad N, Usmani D, Tarique M, Naz H, Ashraf M, Raliya R, Tabrez S, Zughaibi TA, Alsaieedi A, Hakeem IJ, Suhail M. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer. Cells. 2022 Jul 15;11(14). doi: 10.3390/cells11142209. Review. PubMed PMID: 35883653; PubMed Central PMCID: PMC9318484.

select

Ruiz FJ, Sundaresan A, Zhang J, Pedamallu CS, Halle MK, Srinivasasainagendra V, Zhang J, Muhammad N, Stanley J, Markovina S, Tiwari HK, Grigsby PW, Krakstad C, Schwarz JK, Ojesina AI. Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas. Cancers (Basel). 2021 Sep 10;13(18). doi: 10.3390/cancers13184551. PubMed PMID: 34572780; PubMed Central PMCID: PMC8467954.

select

Ruiz FJ, Inkman M, Rashmi R, Muhammad N, Gabriel N, Miller CA, McLellan MD, Goldstein M, Markovina S, Grigsby PW, Zhang J, Schwarz JK. HPV transcript expression affects cervical cancer response to chemoradiation. JCI Insight. 2021 Aug 23;6(16). doi: 10.1172/jci.insight.138734. PubMed PMID: 34255749; PubMed Central PMCID: PMC8409981.

select

Floberg JM, Zhang J, Muhammad N, DeWees TA, Inkman M, Chen K, Lin AJ, Rashmi R, Jayachandran K, Edelson BT, Siegel BA, Dehdashti F, Grigsby PW, Markovina S, Schwarz JK. Standardized Uptake Value for (18)F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer. Clin Cancer Res. 2021 Aug 1;27(15):4245-4255. doi: 10.1158/1078-0432.CCR-20-4450. Epub 2021 Apr 5. PubMed PMID: 33820781; PubMed Central PMCID: PMC8338789.

select

Federico C, Sun J, Muz B, Alhallak K, Cosper PF, Muhammad N, Jeske A, Hinger A, Markovina S, Grigsby P, Schwarz JK, Azab AK. Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1483-1494. doi: 10.1016/j.ijrobp.2020.11.052. Epub 2020 Nov 27. PubMed PMID: 33253820; PubMed Central PMCID: PMC8592040.

select

Singh SV, Chaube B, Mayengbam SS, Singh A, Malvi P, Mohammad N, Deb A, Bhat MK. Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter. Biochim Biophys Acta Mol Basis Dis. 2021 Mar 1;1867(3):166011. doi: 10.1016/j.bbadis.2020.166011. Epub 2020 Nov 16. PubMed PMID: 33212188.

select

Suhail M, Tarique M, Muhammad N, Naz H, Hafeez A, Zughaibi TA, Kamal MA, Rehan M. A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options. Curr Med Chem. 2021;28(21):4117-4132. doi: 10.2174/0929867327666201111142307. Review. PubMed PMID: 33176636.

select

Rashmi R, Jayachandran K, Zhang J, Menon V, Muhammad N, Zahner M, Ruiz F, Zhang S, Cho K, Wang Y, Huang X, Huang Y, McCormick ML, Rogers BE, Spitz DR, Patti GJ, Schwarz JK. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers. Mol Cancer Ther. 2020 Dec;19(12):2465-2475. doi: 10.1158/1535-7163.MCT-20-0271. Epub 2020 Oct 21. PubMed PMID: 33087507; PubMed Central PMCID: PMC8208465.

select

Malvi P, Chaube B, Singh SV, Mohammad N, Vijayakumar MV, Singh S, Chouhan S, Bhat MK. Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state. Cancer Metab. 2018;6:2. doi: 10.1186/s40170-018-0176-5. eCollection 2018. PubMed PMID: 29568521; PubMed Central PMCID: PMC5859707.

select

Muhammad N, Steele R, Isbell TS, Philips N, Ray RB. Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death. Oncotarget. 2017 Sep 12;8(39):66226-66236. doi: 10.18632/oncotarget.19887. eCollection 2017 Sep 12. PubMed PMID: 29029506; PubMed Central PMCID: PMC5630406.

select

Muhammad N, Bhattacharya S, Steele R, Phillips N, Ray RB. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2017 Jun 15;23(12):3120-3128. doi: 10.1158/1078-0432.CCR-16-2811. Epub 2016 Dec 13. PubMed PMID: 27965308; PubMed Central PMCID: PMC5468504.

select

Bhattacharya S, Muhammad N, Steele R, Kornbluth J, Ray RB. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells. Cancer Prev Res (Phila). 2017 Jun;10(6):337-344. doi: 10.1158/1940-6207.CAPR-17-0046. Epub 2017 May 2. PubMed PMID: 28465362; PubMed Central PMCID: PMC5499682.

select

Singh S, Chouhan S, Mohammad N, Bhat MK. Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3. FEBS Lett. 2017 May;591(10):1371-1382. doi: 10.1002/1873-3468.12655. Epub 2017 May 6. PubMed PMID: 28417458.

select

Malvi P, Chaube B, Singh SV, Mohammad N, Pandey V, Vijayakumar MV, Radhakrishnan RM, Vanuopadath M, Nair SS, Nair BG, Bhat MK. Weight control interventions improve therapeutic efficacy of dacarbazine in melanoma by reversing obesity-induced drug resistance. Cancer Metab. 2016;4:21. doi: 10.1186/s40170-016-0162-8. eCollection 2016. PubMed PMID: 27980732; PubMed Central PMCID: PMC5142287.

select

Muhammad N, Bhattacharya S, Steele R, Ray RB. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget. 2016 Sep 6;7(36):58595-58605. doi: 10.18632/oncotarget.11193. Review. PubMed PMID: 27517632; PubMed Central PMCID: PMC5295456.

select

Bhattacharya S, Muhammad N, Steele R, Peng G, Ray RB. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth. Oncotarget. 2016 May 31;7(22):33202-9. doi: 10.18632/oncotarget.8898. PubMed PMID: 27120805; PubMed Central PMCID: PMC5078086.

select

Chaube B, Malvi P, Singh SV, Mohammad N, Meena AS, Bhat MK. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression. Oncotarget. 2015 Nov 10;6(35):37281-99. doi: 10.18632/oncotarget.6134. PubMed PMID: 26484566; PubMed Central PMCID: PMC4741930.

select

Mohammad N, Singh SV, Malvi P, Chaube B, Athavale D, Vanuopadath M, Nair SS, Nair B, Bhat MK. Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex. Sci Rep. 2015 Jul 7;5:11853. doi: 10.1038/srep11853. PubMed PMID: 26149967; PubMed Central PMCID: PMC4493576.

select

Malvi P, Chaube B, Pandey V, Vijayakumar MV, Boreddy PR, Mohammad N, Singh SV, Bhat MK. Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: role of adipokines. Mol Oncol. 2015 Mar;9(3):689-703. doi: 10.1016/j.molonc.2014.11.006. Epub 2014 Nov 26. PubMed PMID: 25499031; PubMed Central PMCID: PMC5528703.

select

Mohammad N, Malvi P, Meena AS, Singh SV, Chaube B, Vannuruswamy G, Kulkarni MJ, Bhat MK. Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Mol Cancer. 2014 Sep 1;13:204. doi: 10.1186/1476-4598-13-204. PubMed PMID: 25178635; PubMed Central PMCID: PMC4175626.

select

Meena AS, Sharma A, Kumari R, Mohammad N, Singh SV, Bhat MK. Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved. PLoS One. 2013;8(4):e61524. doi: 10.1371/journal.pone.0061524. Print 2013. PubMed PMID: 23613870; PubMed Central PMCID: PMC3629035.